Contact this trialFirst, we need to learn more about you.
Anti-tumor antibiotic
Chemotherapy Regimen for Multiple Myeloma
Recruiting1 awardPhase 2
Little Rock, Arkansas
This trial is testing a new chemotherapy regimen for myeloma patients who have already had treatment. Results from past studies conducted at MIRT show that patients treated with this new regimen have longer remissions and better responses to treatment than patients who received standard chemotherapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.